How McLaren F1 Tech Is Supercharging The World's Industries
ONE MORNING IN March 2012, GlaxoSmithKline engineer Shaun Glover visited the McLaren Technology Group headquarters in Woking, Surrey. A year earlier, McLaren’s CEO and founder Ron Dennis and Andrew Wi...
Sanofi Pasteur
Sanofi Pasteur is the vaccines division of the multinational pharmaceutical company Sanofi. Sanofi Pasteur is the largest company in the world devoted entirely to vaccines.
In 1994, Aventis merged...
How McLaren F1 Tech Is Supercharging The World's Industries
ONE MORNING IN March 2012, GlaxoSmithKline engineer Shaun Glover visited the McLaren Technology Group headquarters in Woking, Surrey. A year earlier, McLaren’s CEO and founder Ron Dennis and Andrew Wi...
Alan John Beale
Alan John Beale (23 July 1923 - 9 December 2005), more commonly known as John Beale, was a leading expert on vaccines and viruses. While working for Glaxo, he was responsible for starting the industr...
Alan John Beale - Wikipedia
Novartis Foundation
The Novartis Foundation was a scientific and educational charity, formed in 1949 by the Swiss company Ciba, now Novartis, and dissolved in 2008. It was the direct successor to the Ciba Foundation, and...
GW0742
GW0742 (also known as GW610742) is a PPARδ/β agonist that is investigated for drug use by GlaxoSmithKline.
Piperacillin
Piperacillin is an extended-spectrum beta-lactam antibiotic of the ureidopenicillin class. It is normally used together with a beta-lactamase inhibitor, notably in the combination piperacillin/tazobac...
Piperacillin - Wikipedia
David Jack (scientist)
Sir David Jack CBE FRS FRSE (22 February 1924 – 8 November 2011) was a Scottish pharmacologist and medicinal chemist who specialised in the development of drugs for treating asthma. He was head of res...
David Jack (scientist) - Wikipedia
Inotuzumab ozogamicin
Inotuzumab ozogamicin (CMC-544) is an antibody-drug conjugate for the treatment of cancers. It consists of the humanized monoclonal antibody inotuzumab (for CD22), linked to a cytotoxic agent from the...
Bimagrumab
Bimagrumab (BYM338) is a human monoclonal antibody developed by Novartis to treat pathological muscle loss and weakness. On August 20, 2013 it was announced that bimagrumab was granted breakthrough th...
Stamulumab
Stamulumab (MYO-029) is an experimental myostatin inhibiting drug developed by Wyeth Pharmaceuticals for the treatment of muscular dystrophy (MD). Stamulumab was formulated and tested by Wyeth in Coll...
MacFarlan Smith
MacFarlan Smith is a Gorgie, Edinburgh based Scottish pharmaceutical research company, founded in 1815. It is part of the Fine Chemical and Catalysts division of Johnson Matthey plc.
J.F. Macfarla...
Anrukinzumab
Anrukinzumab (IMA-638) is a humanized monoclonal antibody designed for the treatment of asthma.Anrukinzumab was developed by Wyeth.
Serelaxin
Serelaxin (RLX030) is an investigational drug for the treatment of acute heart failure (AHF), targeting the relaxin receptor. Serelaxin is a recombinant form of human relaxin-2, a hormone that (among ...
Ozanezumab
Ozanezumab is a monoclonal antibody designed for the treatment of ALS and multiple sclerosis.Ozanezumab targets a protein called Neurite Outgrowth Inhibitor (NOGO-A) or Reticulon 4. NOGO-A is a protei...
SynCo Bio Partners
SynCo Bio Partners B.V. is a biopharmaceutical good manufacturing practices (GMP) contract manufacturing organization (CMO) located in Amsterdam, the Netherlands, licensed for clinical and commercial ...
Marjorie Yang
Marjorie Yang Mun-tak (Traditional Chinese: 楊敏德), GBS (2013), is Chairman of Esquel Group, a leading Hong Kong-based textile and apparel manufacturer with operations throughout the world, producing ov...
American Cyanamid
American Cyanamid Company was a leading American conglomerate which became one of the nation's top 100 manufacturing companies during the 1970s and beyond, according to the Fortune 500 listings at the...
United States v. GlaxoSmithKline
United States v. GlaxoSmithKline was a case before the United States District Court for the Eastern District of Pennsylvania. Robert J. Merena was one of the first who filed claims against SmithKline ...
United States v. GlaxoSmithKline - Wikipedia
Novartis
Novartis International AG is a Swiss multinational pharmaceutical company based in Basel, Switzerland, ranking number one in sales (57.9 billion US$) among the world-wide industry in 2013.Novarti...
Fezakinumab
Fezakinumab is a human monoclonal antibody against interleukin-22, designed for the treatment of psoriasis and rheumatoid arthritis. Wyeth discovered and initially developed the drug, and clinical dev...
Medochemie
Medochemie Ltd is multinational pharmaceutical and technologically advanced international generics pharmaceutical as well as consumer healthcare company in Europe, headquartered in Limassol, Cyprus. M...
Genomics Institute of the Novartis Research Foundation
The Genomics Institute of the Novartis Research Foundation (GNF) is a research institution specializing in basic biological as well as drug discovery research using high-throughput techniques. The ins...
Genomics Institute of the Novartis Research Foundation - Wikipedia